The Path to Better MRSA Control
How Active Surveillance and Molecular Tests Can Reduce Infections and Transmission
By Deborah Levenson
Molecular tests that rapidly identify carriers of methicillin-resistant Staphylococcus aureus can be an important part of comprehensive, active surveillance plans, but at far greater up-front cost than conventional culture methods. But with effective systems of care that ensure timely response to results, molecular tests may offset the huge costs associated with treating MRSA infections.
Critical Result Reporting
Can IT and Improved Communication Systems Help Labs Meet Patient Safety Standards?
By Julie McDowell
The Joint Commission’s newly released 2008 National Patient Safety Goals once again feature critical test result and value reporting requirements for laboratories. Laboratory leaders and commission officials emphasize the importance of correct interpretation of the goals, the role of IT tools in improving communication between the laboratory and caregivers, and how to streamline a critical value reporting system to maximize efficiency.
Celiac Disease
How Serological Tests Can Improve Diagnosis
By Robin G. Lorenz, MD, PhD
Now recognized as an under-diagnosed disorder, patients with celiac disease can present with the classical symptoms of diarrhea and failure to thrive, or with an atypical and silent presentation. Find out how serological tests are improving diagnosis of these patients.
Download the entire issue
Next Month
Universal Thyroid Screening in Pregnancy
Competitive Bidding Moves Forward
About AACC | Members | Events | Government & Public Affairs | Resource Centers | Professional Development | Publications
Home | Contact Us | FAQ | Site Map | Join AACC | Privacy Policy and Legal Disclaimer | New Account
©2008 American Association for Clinical Chemistry1850 K Street, NW Suite 625 Washington, DC 20006
Phone: (800) 892-1400 Fax: (202) 887-5093